Perez-Padilla Rogelio, de la Rosa-Zamboni Daniela, Ponce de Leon Samuel, Hernandez Mauricio, Quiñones-Falconi Francisco, Bautista Edgar, Ramirez-Venegas Alejandra, Rojas-Serrano Jorge, Ormsby Christopher E, Corrales Ariel, Higuera Anjarath, Mondragon Edgar, Cordova-Villalobos Jose Angel
National Institute of Respiratory Diseases, Mexico City, Mexico.
N Engl J Med. 2009 Aug 13;361(7):680-9. doi: 10.1056/NEJMoa0904252. Epub 2009 Jun 29.
In late March 2009, an outbreak of a respiratory illness later proved to be caused by novel swine-origin influenza A (H1N1) virus (S-OIV) was identified in Mexico. We describe the clinical and epidemiologic characteristics of persons hospitalized for pneumonia at the national tertiary hospital for respiratory illnesses in Mexico City who had laboratory-confirmed S-OIV infection, also known as swine flu.
We used retrospective medical chart reviews to collect data on the hospitalized patients. S-OIV infection was confirmed in specimens with the use of a real-time reverse-transcriptase-polymerase-chain-reaction assay.
From March 24 through April 24, 2009, a total of 18 cases of pneumonia and confirmed S-OIV infection were identified among 98 patients hospitalized for acute respiratory illness at the National Institute of Respiratory Diseases in Mexico City. More than half of the 18 case patients were between 13 and 47 years of age, and only 8 had preexisting medical conditions. For 16 of the 18 patients, this was the first hospitalization for their illness; the other 2 patients were referred from other hospitals. All patients had fever, cough, dyspnea or respiratory distress, increased serum lactate dehydrogenase levels, and bilateral patchy pneumonia. Other common findings were an increased creatine kinase level (in 62% of patients) and lymphopenia (in 61%). Twelve patients required mechanical ventilation, and seven died. Within 7 days after contact with the initial case patients, a mild or moderate influenza-like illness developed in 22 health care workers; they were treated with oseltamivir, and none were hospitalized.
S-OIV infection can cause severe illness, the acute respiratory distress syndrome, and death in previously healthy persons who are young to middle-aged. None of the secondary infections among health care workers were severe.
2009年3月下旬,墨西哥发现了一起呼吸道疾病疫情,后来证实是由新型猪源甲型流感病毒(S-OIV)引起的。我们描述了在墨西哥城全国性三级呼吸疾病医院因肺炎住院且实验室确诊感染S-OIV(又称猪流感)的患者的临床和流行病学特征。
我们采用回顾性病历审查来收集住院患者的数据。通过实时逆转录聚合酶链反应检测法在标本中确认S-OIV感染。
2009年3月24日至4月24日,在墨西哥城国家呼吸疾病研究所因急性呼吸道疾病住院的98名患者中,共确诊18例肺炎且感染S-OIV。18例患者中超过一半年龄在13至47岁之间,只有8例有既往病史。18例患者中有16例是首次因该病住院;另外2例患者是从其他医院转诊而来。所有患者均有发热、咳嗽、呼吸困难或呼吸窘迫、血清乳酸脱氢酶水平升高以及双侧斑片状肺炎。其他常见表现为肌酸激酶水平升高(62%的患者)和淋巴细胞减少(61%)。12例患者需要机械通气,7例死亡。在与首例患者接触后的7天内,22名医护人员出现了轻度或中度流感样疾病;他们接受了奥司他韦治疗,无人住院。
S-OIV感染可导致先前健康的中青年人群患上严重疾病、急性呼吸窘迫综合征并死亡。医护人员中的继发感染均不严重。